|
ATCC
mic ![]() Mic, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mic/MIC/pmc09927234-71-15-17 Average 99 stars, based on 1 article reviews
mic - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
BioVendor Instruments
serum gdf15 expression ![]() Serum Gdf15 Expression, supplied by BioVendor Instruments, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mic/GDF-15%2FMIC-1+Human+ELISA/pm23787477-103-0-7 Average 94 stars, based on 1 article reviews
serum gdf15 expression - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Proteintech
anti mica ![]() Anti Mica, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mic/MICA+Antibody/pm37591356-89-35-37 Average 93 stars, based on 1 article reviews
anti mica - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Proteintech
anti gdf15 antibody ![]() Anti Gdf15 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mic/GDF15+Antibody/pmc12523146-54-16-19 Average 94 stars, based on 1 article reviews
anti gdf15 antibody - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
OriGene
pcmv myc gdf15 ![]() Pcmv Myc Gdf15, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mic/GDF15+(NM_004864)+Human+Tagged+ORF+Clone/pmc04262834-111-17-21 Average 90 stars, based on 1 article reviews
pcmv myc gdf15 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
OriGene
gdf15 human tagged orf ![]() Gdf15 Human Tagged Orf, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mic/GDF15+(NM_004864)+Human+Tagged+ORF+Clone/pmc11999475-60-16-22 Average 93 stars, based on 1 article reviews
gdf15 human tagged orf - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
MedChemExpress
rmcxcl1 ![]() Rmcxcl1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mic/GDF-15%2C+Mouse/pm39048054-352-27-28 Average 93 stars, based on 1 article reviews
rmcxcl1 - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Cell Signaling Technology Inc
anti e cadherin ![]() Anti E Cadherin, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mic/Mic-1+(Y60)+Antibody/pmc08108040-87-21-23 Average 92 stars, based on 1 article reviews
anti e cadherin - by Bioz Stars,
2026-11
92/100 stars
|
Buy from Supplier |
|
ABclonal Biotechnology
plasma protein gdf15 ![]() Plasma Protein Gdf15, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mic/GDF15+Rabbit+pAb/pm38631604-68-0-18 Average 94 stars, based on 1 article reviews
plasma protein gdf15 - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Qkine Ltd
human recombinant gdf ![]() Human Recombinant Gdf, supplied by Qkine Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mic/human+GDF-15/bio_rxiv__64898__2026__06__24__734341-210-0-5 Average 94 stars, based on 1 article reviews
human recombinant gdf - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Cell Signaling Technology Inc
anti gdf15 antibody ![]() Anti Gdf15 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mic/Mic-1+Rabbit+mAb/pmc08673705-92-7-12 Average 94 stars, based on 1 article reviews
anti gdf15 antibody - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
TargetMol
dose rmgdf15 ![]() Dose Rmgdf15, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mic/GDF-15+Protein%2C+Mouse%2C+Recombinant/pm42873832-263-5-10 Average 94 stars, based on 1 article reviews
dose rmgdf15 - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Microbiology Spectrum
Article Title: Mechanism of Action of Isopropoxy Benzene Guanidine against Multidrug-Resistant Pathogens
doi: 10.1128/spectrum.03469-22
Figure Lengend Snippet: IBG restores the sensitivity of colistin against Gram-negative bacteria. (A) Chemical structure of the IBG. The guanidine group is marked in red. (B) Inhibition rate of colistin combined with IBG against 30 Gram-negative bacteria. (C and D) Time-kill assays conducted with colistin (0.5× MIC), IBG monotherapy (10 μg/mL), the combination, or later addition of colistin or IBG against colistin-susceptible E. coli ATCC 25922 (C) and colistin-resistant E. coli SHP45 (D).
Article Snippet: We found that colistin monotherapy produced highly resistant strains with a 64-fold increase in the MIC for
Techniques: Bacteria, Inhibition
Journal: Microbiology Spectrum
Article Title: Mechanism of Action of Isopropoxy Benzene Guanidine against Multidrug-Resistant Pathogens
doi: 10.1128/spectrum.03469-22
Figure Lengend Snippet: Antibacterial activity of IBG
Article Snippet: We found that colistin monotherapy produced highly resistant strains with a 64-fold increase in the MIC for
Techniques: Activity Assay, Bacteria
Journal: Microbiology Spectrum
Article Title: Mechanism of Action of Isopropoxy Benzene Guanidine against Multidrug-Resistant Pathogens
doi: 10.1128/spectrum.03469-22
Figure Lengend Snippet: Evolution of colistin resistance in colistin-susceptible and colistin-resistant E. coli . The fold change of colistin MIC was detected after colistin-susceptible E. coli ATCC 25922 (A) and colistin-resistant E. coli SHP45 (B) were treated with 0.5× MIC colistin alone or in combination with IBG at 5 μg/mL or 10 μg/mL in vitro .
Article Snippet: We found that colistin monotherapy produced highly resistant strains with a 64-fold increase in the MIC for
Techniques: In Vitro
Journal: Microbiology Spectrum
Article Title: Mechanism of Action of Isopropoxy Benzene Guanidine against Multidrug-Resistant Pathogens
doi: 10.1128/spectrum.03469-22
Figure Lengend Snippet: Antibacterial mechanism of IBG against MDR bacteria. (A) Dynamic curves of the outer membrane probed with NPN in E. coli ATCC 25922 treated with IBG (10 μg/mL), colistin (0.12 μg/mL), and both together. The fluorescence was detected with excitation and emission wavelengths of 350 nm and 420 nm. (B) The ΔpH after treatment with different concentrations of IBG (from 0 to 10× MIC) was determined in S. aureus ATCC 29213. The means for three biological replicates are shown, and error bars represent the SD. (C) Levels of intracellular ATP in S. aureus ATCC 29213 after treatment of IBG. Nonparametric one-way analysis of variance (ANOVA) was used to calculate P values (*, P < 0.05; **, P < 0.01). (D) Accumulation of ROS in E. coli ATCC 25922 treated with IBG with or without 0.12 μg/mL colistin. (E) IBG inhibits the transcript level of mcr -1 in E. coli SHP45 determined by qRT-PCR. All data are means and SD, and significance was determined by nonparametric one-way ANOVA (**, P < 0.01). (F) Scheme of mechanisms of action of IBG in Gram-positive and Gram-negative bacteria.
Article Snippet: We found that colistin monotherapy produced highly resistant strains with a 64-fold increase in the MIC for
Techniques: Bacteria, Membrane, Fluorescence, Quantitative RT-PCR
Journal: BMC Cancer
Article Title: Unveiling GDF15 as a promising biomarker for predicting survival in pancreatic ductal carcinoma: a retrospective research
doi: 10.1186/s12885-025-14963-7
Figure Lengend Snippet: IHC results of GDF15 level in PDAC and normal pancreas tissues. a Immunohistochemical analysis revealed markedly elevated GDF15 expression in pancreatic ductal adenocarcinoma (PDAC) specimens, whereas adjacent non‑neoplastic pancreatic tissues showed little to no detectable GDF15 staining. b Patients with poor prognoses exhibited higher expression levels compared to those with more favorable outcomes. c H‑score results for GDF15 expression were graphically represented, revealing a statistically significant difference in staining intensity between PDAC tumor tissues and their adjacent non‑neoplastic counterparts
Article Snippet: The TMAs were prepared using a PV-9000 IHC kit (ZSGB-BIO, Beijing, China) and incubated with an
Techniques: Immunohistochemical staining, Expressing, Staining
Journal: BMC Cancer
Article Title: Unveiling GDF15 as a promising biomarker for predicting survival in pancreatic ductal carcinoma: a retrospective research
doi: 10.1186/s12885-025-14963-7
Figure Lengend Snippet: OS of PDAC patients with different GDF15 levels. Patients exhibiting low GDF15 expression showed significantly longer overall survival than those with high expression, as demonstrated by Kaplan–Meier analysis.
Article Snippet: The TMAs were prepared using a PV-9000 IHC kit (ZSGB-BIO, Beijing, China) and incubated with an
Techniques: Expressing
Journal: Redox Biology
Article Title: Repression of oxidative phosphorylation by NR2F2, MTERF3 and GDF15 in human skin under high-glucose stress
doi: 10.1016/j.redox.2025.103613
Figure Lengend Snippet: GDF15 biosynthesis is indispensable for human skin reconstruction . A) The effect of 100 nM GDF15 supplementation was determined using comparative proteomics on HDFs exposed to 12 mM glucose for 48H . The pathway analysis is shown as a bubble volcano plot (significant pathways with -logAdjPvalue>1.3 are shown. The pathways with blue dots are inhibited while pathways with orange dots are activated. The number of proteins detected for each pathway is represented by the diameter of each dot. Activation or inhibition was determined using the Z-score calculated by IPA Qiagen. B) Proteins of the Wound Healing Signaling, AMPK Signaling, Oxidative Phosphorylation or Protein Kinase A Signaling altered by the 12 mM glucose treatment are shown. C ) Human skin reconstruction was performed using fiboblasts expressing a shGDF15, wild-type fibroblasts exposed to 12 mM glucose or wild-type fibroblasts exposed to 12 mM glucose and supplemented with 2 nM GDF15. development. Macroscopic view is shown with a scale bar of 0.6 cm, D) Immunofluorescence study of HRS using DAPI marker (blue), Collagen I (yellow) and MKi67 (pink). Scale bar. 50 μM, N = 3. E , F ) Migration assay of HDF cultivated in 5.55 mM, 12 mM or 25 mM glucose and HDF cultivated in 12 mM glucose supplemented with 100 nM gdf15, HDF transfected with esiGDF15 or esiTFAM (N = 15). All data were expressed as the mean ± SEM. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001. Ordinary one-way ANOVA with Dunett's test correction was used for panel F.
Article Snippet: Expression plasmids in lentiviral vectors were purchased for MTERF3 Human Tagged ORF Clone (#RC201030L4, Origene) and
Techniques: Activation Assay, Inhibition, Phospho-proteomics, Expressing, Immunofluorescence, Marker, Migration, Transfection
Journal: Redox Biology
Article Title: Repression of oxidative phosphorylation by NR2F2, MTERF3 and GDF15 in human skin under high-glucose stress
doi: 10.1016/j.redox.2025.103613
Figure Lengend Snippet: cFOS and NR2F2 transcription factors mediate glucose-dependent repression of GDF15 in human dermis. A) Determination by Simple WES of the protein expression level of proGDF15 in wild-type HDF expressing shcontrol or shGDF15 (N = 3). B) Expression of GDF15 in the skin from human protein expression atlas from EMBL-EBI ( https://www.ebi.ac.uk ) which includes RNA-seq analyses from tissue samples of 122 human individuals, representing 32 different tissues. The results are expressed as TPM (Transcripts Per Kilobase Million). C) Quantification of GDF15 mRNA transcripts by taqman quantitative PCR in HDF, A549 and HEPG2 (N = 3). D) Quantification of GDF15 mRNA transcripts by taqman quantitative PCR in HDF, 786-O and SN005 cells (N = 3). E) ELISA-Based Quantification of GDF15 secretion in HDFs. HDFs were cultured under conditions of normal (5.5 mM) and high (12 mM) glucose concentrations during 48h. GDF15 levels in the culture supernatants were quantified using an enzyme-linked immunosorbent assay (ELISA) following the manufacturer's instructions. F) Quantification of GDF15 mRNA transcripts by taqman quantitative PCR in HDF grown in 5.55 mM, 12 mM or 25 mM glucose (N = 3). G) GDF15 promoter activity in HDF grown 24 h in DMEM with 5.55 mM,12 mM or 25 mM of glucose or 5.55 mM of galactose (N = 4). H) Dose-dependent relationship between GDF15 promoter activation and glucose concentration in the medium. I) GDF15 gene promoter sequence with identification of the binding site for the FOS transcription factor (Swiss Regulon Expasy). J) Quantification of FOS mRNA transcript by taqman quantitative PCR in HDF cultivated in 5.55 mM or 12 mM glucose (N = 3). K) Determination by Simple WES of FOS protein expression level in HDF cultivated in 5.55 mM or 12 mM glucose (N = 3). L-M) Determination by Simple WES of GDF15 protein expression level in HDF transfected with esiFOS (N = 3). N) Quantification of GDF15 mRNA transcript by taqman quantitative PCR in HDF transfected with esiNR2F2 (N = 3). O) Quantification of GDF15 mRNA transcript by taqman quantitative PCR in HDF expressing sgControl, sgRNA 1 targeting NR2F2 and sgRNA2 targeting NR2F2. Normalization of the data to GusB (β-glucuronidase), N = 3. P–S) Quantification of ATF3, ATF4, CHOP and P53 mRNA transcripts by taqman quantitative PCR in HDF expressing siCTRL and esiNR2F2 in 5.5 mM glucose or 12 mM glucose growth medium. Normalization of the data to GusB (β-glucuronidase), N = 3. T) Schematic representation of the NR2F2-MTERF3-GDF15 axis and its control on OXPHOS function in response to glucose stress. All data are expressed as the mean ± SEM. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001. Ordinary one-way ANOVA with Dunett's test correction was used for panel C, E and N. Unpaired t -test was used for panels A, B, H, I, J, K, L and M.
Article Snippet: Expression plasmids in lentiviral vectors were purchased for MTERF3 Human Tagged ORF Clone (#RC201030L4, Origene) and
Techniques: Expressing, RNA Sequencing, Real-time Polymerase Chain Reaction, Enzyme-linked Immunosorbent Assay, Cell Culture, Activity Assay, Activation Assay, Concentration Assay, Sequencing, Binding Assay, Transfection, Control
Journal: Redox Biology
Article Title: Repression of oxidative phosphorylation by NR2F2, MTERF3 and GDF15 in human skin under high-glucose stress
doi: 10.1016/j.redox.2025.103613
Figure Lengend Snippet: GDF15 inhibition by hyperglycemia or shRNA alters mitochondrial biogenesis. A) Metabolomic profile of HDF grown 48H in DMEM with 5.55 mM or 12 mM + 100 nM GDF15 of glucose and HDF expressing a shGDF15 cultivated in 5.55 mM glucose (N = 3). B) Oxygen consumption rate (OCR) was measured using the Seahorse XFe96. Routine respiration and uncoupled respiration (CCCP) were determined in HDF grown in 5.55 mM glucose and HDF expressing shGDF15 grown in 5.55 mM glucose or 5.55 mM glucose supplemented with 100 nM gdf15. C) Oxygen consumption rate (OCR) was measured using the Seahorse XFe96. Routine respiration and uncoupled respiration (CCCP) were determined in HDF grown in 5.55 mM glucose and supplemented with low doses of gdf15: 20pM, 80pM, 1 nM, 10 nM and 100 nM. D) Mitochondrial respiratory chain proteins (gene loci) specifically activated at the level of chromatin accessibility by GDF15 100 nM. E-H) Quantification of mRNA transcripts by taqman quantitative PCR for NR2F2, GDF15, MTERF3 and TFAM in HDF cultivated with 5.55 mM glucose or 5.55 mM glucose supplemented with 100 nM gdf15. Normalization of the data was performed to GusB (β-glucuronidase), N = 3. I-L) Quantification of mRNA transcripts by taqman quantitative PCR for GDF15, MAPK1, MAPK3, PGC1α (Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha) in HDF cultivated with 5.55 mM glucose supplemented with low doses of gdf15. Normalization of the data was performed to GusB (β-glucuronidase), N = 3 M) Quantification of TFAM mRNA transcripts by taqman quantitative PCR in HDF cultivated with 5.55 mM, 12 mM or 25 mM glucose or in HDF expressing shGDF15 grown in 5.55 mM glucose. Normalization of data was performed to GusB (β-glucuronidase), N = 3. N) Quantification of PGC1α mRNA transcript by taqman quantitative PCR in HDF cultivated with 5.55 mM, 12 mM or 25 mM glucose or in HDF expressing shGDF15 grown in 5.55 mM glucose. Normalization of the data to GusB (β-glucuronidase), N = 3. O) Quantification of PGC1α mRNA transcript by taqman quantitative PCR in HDF transfected with esiNR2F2. Normalization of data to GusB (β-glucuronidase), N = 3. P,Q) Quantification of the total Coenzyme Q10 (oxidized and reduced forms) in HDF cultivated with 5.55 mM, 12 mM or 12 mM glucose medium supplemented with 100 nM gdf15. Analysis was also performed in HDF expressing shGDF15 in 5.55 mM glucose. R) Quantification of TFAM in HDF cultivated with 5.55 mM glucose medium or medium supplemented with 20pM, 100 pM and 100 nM rGDF15. S) Summary of the regulatory network linking TFAM, PGC1α, COQ9 and COQ10. All data are expressed as the mean ± SEM. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001. Ordinary one-way ANOVA with Dunett's test correction was used for panel A, B, F, G, I-M, P–R. Unpaired t -test was used for panels E, H and O.
Article Snippet: Expression plasmids in lentiviral vectors were purchased for MTERF3 Human Tagged ORF Clone (#RC201030L4, Origene) and
Techniques: Inhibition, shRNA, Expressing, Real-time Polymerase Chain Reaction, Transfection
Journal: bioRxiv
Article Title: Therapy-induced senescent-like cancer cells drive macrophage-mediated immunosuppression in cholangiocarcinoma
doi: 10.64898/2026.06.24.734341
Figure Lengend Snippet: (A) Proteome Profiler Human XL cytokine array (105 cytokines) of conditioned medium from proliferating, doxorubicin-induced (Dox), and Gem/Cis-induced senescent-like RBE cells. (B) Gdf15 mRNA in proliferating versus senescent-like murine CCA (SB1) cells. (C) Gdf15 mRNA in control vs AP-treated SB-p16-ATTAC tumors. (D) Schematic of in vitro studies. (E-F) Arg1 and iNOS mRNA in bone-marrow-derived macrophage (BMDM) incubated for 72 h with conditioned medium from vehicle- or alisertib-treated SB1 cells expressing shCtrl or shGdf15 . (G) Bulk RNA-seq heatmap (row Z-scores) of naïve bone marrow-derived macrophages (BMDM) cultured 72 h with conditioned media (CM) from SB-p16-shCtrl or SB- p16-Gdf15 OE cells. (H) ARG1 mRNA in human monocyte-derived macrophages ± recombinant human GDF-15 (Qkine Qk017; TGF-β1-free), qRT-PCR relative to vehicle; mean ± SEM, n = 6. (I) Division index (CFSE dilution, normalized to T-cells-only) of anti-CD3/CD28-activated CD8⁺ T cells co-cultured with BMDMs incubated for 72 h with conditioned medium from vehicle- or alisertib-treated SB1 cells expressing shCtrl or shGdf15 . Data are mean ± SEM; *, P<0.05; **, P<0.01; ****, P<0.0001; ns, not significant.
Article Snippet:
Techniques: Control, In Vitro, Derivative Assay, Incubation, Expressing, RNA Sequencing, Cell Culture, Recombinant, Quantitative RT-PCR
Journal: bioRxiv
Article Title: Therapy-induced senescent-like cancer cells drive macrophage-mediated immunosuppression in cholangiocarcinoma
doi: 10.64898/2026.06.24.734341
Figure Lengend Snippet: (A) Macrophages express TGFBR2, the candidate non-canonical GDF-15 receptor, in murine and human CCA single-cell RNA-seq. (B) α-TGFBR2 western blot (WB) of streptavidin pull-down (top) and input (middle) from naïve BMDMs treated with biotin-supplemented conditioned media (CM) from CCA cells expressing GDF-15-BioID2-HA or SEC61B-BioID2-HA (ER control); α-HA blot of CM (bottom) confirms bait secretion. (C) GDF-15 induces macrophage phospho-STAT6 but not phospho-SMAD2/3, reflecting non-canonical TGFBR2 output. (D) WB of BMDMs stimulated with control or GDF-15-overexpressing (GDF-15 OE ) CM for 0 or 1 h: p-STAT6, STAT6, p-SMAD3, SMAD3. (E) Arg1 mRNA in BMDMs transfected with siCtrl or siTgfbr2 and stimulated with control or rGDF-15. n = 6. Data are mean ± SEM; *, P<0.05; **, P<0.01; ****, P<0.0001; ns, not significant.
Article Snippet:
Techniques: Single Cell, RNA Sequencing, Western Blot, Expressing, Control, Transfection
Journal: bioRxiv
Article Title: Therapy-induced senescent-like cancer cells drive macrophage-mediated immunosuppression in cholangiocarcinoma
doi: 10.64898/2026.06.24.734341
Figure Lengend Snippet: (A) Strategy for p16-promoter-restricted Gdf15 silencing (shRNA) and Gdf15 overexpression. (B) qPCR validation of Gdf15 knockdown and overexpression in senescent-like SB1 cells. (C-D) Subcutaneous model and tumor-burden quantification. (E) GeoMx spatial profiling of GDF-15 expression and macrophage infiltration in human CCA. Region-of-interest (ROI)-level analysis plotting GDF-15 expression against macrophage score; each point is one ROI, with the linear fit and 95% confidence band shown. Spearman ρ = 0.63, P = 0.0067. Data are mean ± SEM; **, P<0.01; ****, P<0.0001.
Article Snippet:
Techniques: shRNA, Over Expression, Biomarker Discovery, Knockdown, Expressing